During the last few decades, improvements in the planning and application of radiotherapy in combination with surgery and chemotherapy resulted in increased survival rates of tumor patients. However, the success of radiotherapy is impaired by two reasons: firstly, the radioresistance of tumor cells and, secondly, the radiation-induced damage of normal tissue cells located in the field of ionizing radiation. These limitations demand the development of drugs for either radiosensitization of tumor cells or radioprotection of normal tissue cells. In order to identify potential targets, a detailed understanding of the cellular pathways involved in radiation response is an absolute requirement. This review describes the most important pathways of radioresponse and several key target proteins for radiosensitization.
CITATION STYLE
Maier, P., Hartmann, L., Wenz, F., & Herskind, C. (2016, January 14). Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms17010102
Mendeley helps you to discover research relevant for your work.